These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22888624)

  • 1. [Introduction of pharmacovigilance in a new university hospital in Morocco: how and why].
    Khabbal Y; Alami L; Nejjari C
    East Mediterr Health J; 2012 Jun; 18(6):648-52. PubMed ID: 22888624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical pharmacy and pharmacovigilance over a period of nine years in hospital].
    Guédat MG; Gouraud A; Ramiah T; Demazière J; Delanoy B; Vial T; Leboucher G; Charpiat B
    Therapie; 2012; 67(3):243-50. PubMed ID: 22874491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events associated with the use of complementary medicine and health supplements: an analysis of reports in the Singapore Pharmacovigilance database from 1998 to 2009.
    Patel DN; Low WL; Tan LL; Tan MM; Zhang Q; Low MY; Chan CL; Koh HL
    Clin Toxicol (Phila); 2012 Jul; 50(6):481-9. PubMed ID: 22738039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new model of pharmacovigilance? A pilot study.
    Zancan A; Locatelli C; Ramella F; Tatoni P; Bacis G; Vecchio S; Manzo L
    Biomed Pharmacother; 2009 Jul; 63(6):451-5. PubMed ID: 18790597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacovigilance in pharmacy practice].
    Duquet N
    J Pharm Belg; 2011 Dec; (4):97-103. PubMed ID: 22299235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New guideline for tramadol usage following adverse drug reactions reported to the Iranian Pharmacovigilance Center.
    Gholami K; Shalviri G; Zarbakhsh A; Daryabari N; Yousefian S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):229-37. PubMed ID: 17063533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug vigilance: opinion survey among residents of a university hospital].
    Graille V; Lapeyre-Mestre M; Montastruc JL
    Therapie; 1994; 49(5):451-4. PubMed ID: 7855763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital.
    Murphy BM; Frigo LC
    Hosp Pharm; 1993 Dec; 28(12):1199-204, 1240. PubMed ID: 10130617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacovigilance].
    Livio F; Renard D; Buclin T
    Rev Med Suisse; 2012 Jan; 8(324):116-9. PubMed ID: 23185821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic adverse drug reactions: a preliminary report from the regional pharmacovigilance center, western Nepal.
    P S; P M; Pr S
    Pak J Pharm Sci; 2008 Oct; 21(4):465-7. PubMed ID: 18930872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of suspected adverse reactions to natural health products in Italy.
    Menniti-Ippolito F; Mazzanti G; Santuccio C; Moro PA; Calapai G; Firenzuoli F; Valeri A; Raschetti R
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):626-35. PubMed ID: 18327867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety aspects of antiepileptic drugs--focus on pharmacovigilance.
    Landmark CJ; Johannessen SI
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):11-20. PubMed ID: 22069221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of hospital and community pharmacists in pharmacovigilance.
    van Grootheest AC; de Jong-van den Berg LT
    Res Social Adm Pharm; 2005 Mar; 1(1):126-33. PubMed ID: 17138470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of pharmacovigilance among resident doctors in Edo and Lagos states of Nigeria.
    Ohaju-Obodo JO; Iribhogbe OI
    Pharmacoepidemiol Drug Saf; 2010 Feb; 19(2):191-5. PubMed ID: 20014358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highlights of the 22nd French pharmacovigilance meeting.
    Prescrire Int; 2002 Feb; 11(57):21-3. PubMed ID: 11985373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.